Loading…
Nutex Health Inc. is projected to rise to $246.18 by 2027, a +34% move from its current price of $183.36. NUTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $176.92 | $183.34 | $189.99 | -0.01% |
| Jul 13 | $174.30 | $183.32 | $192.79 | -0.02% |
| Jul 14 | $172.32 | $183.29 | $194.97 | -0.04% |
| Jul 15 | $170.66 | $183.27 | $196.82 | -0.05% |
| Jul 16 | $169.21 | $183.25 | $198.45 | -0.06% |
| Jul 17 | $167.91 | $183.23 | $199.95 | -0.07% |
| Jul 18 | $166.72 | $183.21 | $201.33 | -0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $166.72 | $183.21 | $201.33 | -0.08% |
| Week 2 | $160.19 | $183.05 | $209.17 | -0.17% |
| Week 3 | $155.33 | $182.90 | $215.35 | -0.25% |
| Week 4 | $151.33 | $182.74 | $220.68 | -0.34% |
| Week 5 | $147.87 | $182.59 | $225.46 | -0.42% |
| Week 6 | $144.80 | $182.44 | $229.85 | -0.50% |
| Week 7 | $142.03 | $182.28 | $233.95 | -0.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate.
The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs.
The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Nutex Health Inc. trades under the symbol NUTX. The current price is $190.71 and the market cap stands at $1.31B, with a rank of 2374. The stock sits in the Healthcare category and is associated with a forecast that shows a neutral stance in 2026 and bullish momentum in subsequent years.
In 2027 the average price is $255.85, rising through 2028 to $319.31 and reaching $510.29 on average by 2030, with continued upside through 2035, 2040, and 2050 (sketching a path to $3,382.25 on average by 2050). These figures illustrate a potential long-run upside, while underscoring that forecasts are estimates, not guarantees.
A major floor 52.5% below — a decisive break under it would weaken the trend.
The nearest floor, 31.8% below — buyers have tended to step in here.
The nearest ceiling, 7.2% above — a clean break opens room to run.
A major ceiling 30.9% above — clearing it would confirm fresh momentum.
Key NUTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NUTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $185.65 | Sell | $183.68 | Sell |
| MA 10 | $182.04 | Buy | $178.86 | Buy |
| MA 20 | $164.69 | Buy | $167.64 | Buy |
| MA 50 | $143.18 | Buy | $148.00 | Buy |
| MA 100 | $122.47 | Buy | $136.08 | Buy |
| MA 200 | $128.77 | Buy | $125.99 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.84 | Neutral |
| Stoch RSI (14) | 26.52 | Neutral |
| CCI (20) | 73.86 | Neutral |
| Williams %R (14) | -25.60 | Info |
| MACD (12,26,9) | 1.20 | Buy |
| ROC (12) | 24.91 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 74.40 | Neutral |
| TRIX (15) | 1.31 | Buy |
| Awesome (5,34) | 35.92 | Buy |
| Ultimate (7,14,28) | 67.55 | Neutral |
| Momentum (10) | 34.81 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 183.23 | Buy |
| ADX (14) | 35.09 | Buy |
| ATR (14) | 4.84 | Info |
The 30-day technical picture is bullish, with RSI(14) at 80 and price action sitting above key moving averages. The SMA50 is $133.84 and the SMA200 is $125.96, with near-term support at $118.88 and resistance at $190.71. Over the next 30 days, the price has traced a range from $146.74 to $247.85, and the stock’s annualized volatility stands around 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $87.01 | $183.36 | $239.22 | 0% | Neutral | |
| $190.41 | $246.18 | $339.89 | +34% | Bullish | |
| $233.22 | $313.09 | $452.71 | +71% | Bullish | |
| $300.62 | $416.49 | $624.21 | +127% | Bullish | |
| $344.29 | $490.55 | $757.58 | +168% | Bullish | |
| $360.50 | $527.04 | $835.40 | +187% | Bullish | |
| $385.53 | $577.39 | $936.74 | +215% | Bullish | |
| $422.50 | $647.34 | $1,072.49 | +253% | Bullish | |
| $565.67 | $885.80 | $1,496.03 | +383% | Bullish | |
| $668.93 | $1,069.70 | $1,839.05 | +483% | Bullish | |
| $1,012.98 | $1,784.75 | $3,304.02 | +873% | Bullish | |
| $1,621.12 | $3,400.19 | $7,000.31 | +17.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $87.01 | $183.36 | $217.80 | +0.00% |
| August 2026 | $147.70 | $175.82 | $215.97 | -4.11% |
| September 2026 | $150.97 | $181.36 | $225.96 | +3.15% |
| October 2026 | $155.10 | $187.81 | $236.81 | +3.55% |
| November 2026 | $151.52 | $184.71 | $235.24 | -1.65% |
| December 2026 | $151.72 | $186.12 | $239.22 | +0.76% |
Click any year to see its month-by-month NUTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NUTX to range from $87.01 to $239.22 through 2026. The $183.36 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The NUTX price prediction for 2027 points to an average of $246.18 (low $190.41, high $339.89) — a potential gain of +34% on today's $183.36. Buyers look set to stay in control over this stretch.
In 2028, NUTX is projected to trade between $233.22 and $452.71, averaging $313.09 — a potential gain of +71% from today's $183.36. That is up +27% on the projected 2027 average. Momentum favours further upside here.
Nutex Health Inc.'s 2029 outlook centres on $416.49, within a $300.62 to $624.21 range. That is up +33% on the projected 2028 average. That marks a +127% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, NUTX could reach as high as $757.58, with a base case around $490.55 and support toward $344.29 — roughly +168% from $183.36. Momentum favours further upside here.
Expect NUTX to range from $360.50 to $835.40 through 2031. The $527.04 average target implies a +187% move from current prices. That is up +7% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The NUTX price prediction for 2032 points to an average of $577.39 (low $385.53, high $936.74) — a potential gain of +215% on today's $183.36. Momentum favours further upside here.
In 2033, NUTX is projected to trade between $422.50 and $1,072.49, averaging $647.34 — a potential gain of +253% from today's $183.36. That is up +12% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Nutex Health Inc.'s 2034 outlook centres on $885.80, within a $565.67 to $1,496.03 range. That is up +37% on the projected 2033 average. That marks a +383% change versus current levels. Momentum favours further upside here.
By 2035, NUTX could reach as high as $1,839.05, with a base case around $1,069.70 and support toward $668.93 — roughly +483% from $183.36. Buyers look set to stay in control over this stretch.
Expect NUTX to range from $1,012.98 to $3,304.02 through 2040. The $1,784.75 average target implies a +873% move from current prices. That is up +67% on the projected 2035 average. Momentum favours further upside here.
The NUTX price prediction for 2050 points to an average of $3,400.19 (low $1,621.12, high $7,000.31) — a potential gain of +17.5x on today's $183.36. Buyers look set to stay in control over this stretch.
Investing $1,000 in NUTX today (≈ 5.453752 NUTX) could be worth
$18,543.77
+$17,543.77 (+1754%) by 2050 · US Dollar
Based on the average projected NUTX price of $3,400.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NUTXwould be worth at today's price.
$1,000 invested in NUTX on Jul 10, 2025 (≈ 8.502678 NUTX) would be worth
$1,559.05
+$559.05 (+55.9%) today · 1.56× · US Dollar
Based on a NUTX entry price of $117.61 vs. today's $183.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $196.53 | $932.99 | -6.7% |
| 1 month ago | $133.61 | $1,372.35 | +37.2% |
| 3 months ago | $101.05 | $1,814.55 | +81.5% |
| 6 months ago | $180.71 | $1,014.64 | +1.5% |
| 1 year ago | $117.61 | $1,559.05 | +55.9% |
| All time (4.3y) ago | $6,000 | $30.56 | -96.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NUTX forecast.
Our base-case forecast reaches $370.00 around 2029.
Implied market cap at $370.00: $2.55B
The multi-year forecast depicts a bullish trajectory with rising average prices and sizable upside from 2027 onward. In 2027, the average price is $255.85 with a 34.2% ROI and bullish sentiment, followed by 2028 at $319.31 (67.4% ROI) and 2029 at $436.68 (129% ROI). By 2030 the average price is $510.29 with a 167.6% ROI and continued bullish momentum into subsequent years (2031 avg $526.61, 2032 $585.72, 2033 $653.38, 2034 $897.05, 2035 $1,105.34, 2040 $1,785.05, and 2050 $3,382.25 with a 1,673.5% ROI).
The forecast also notes strong bullish sentiment through 2050. These projections come with notable uncertainty and are not guarantees. The implied volatility is high, reflecting a wide range of potential outcomes, and investors should consider the inherent risk in long-run forecasts.
Tap a question to reveal the answer.
For 2030, the forecast shows min $347.99, avg $510.29, max $811.29 with an ROI of 167.6% and a bullish sentiment.
The forecast indicates bullish sentiment from 2027 onward with rising average prices and ROI (e.g., 2027 avg $255.85, 2028 avg $319.31, 2029 avg $436.68 and 2030 avg $510.29 with 167.6% ROI). These are estimates, not guarantees.
Yes. The forecast shows a max of $1,120.50 in 2033, with higher max values in later years (e.g., $1,570.52 in 2034, $1,972.49 in 2035, and $3,448.01 in 2040). This indicates a path where $1,000 could be exceeded by 2033.
Current price: $190.71. Market cap: $1.31B. The stock is ranked 2374 by market cap.
The 30-day range is low $146.74 and high $247.85.
Nutex Health Inc. Community Discussion
0Share your Nutex Health Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.